Specialty Chemicals Stocks
Specialty Chemicals: LyondellBasell Industries N.V. owns the largest revenue base; Sociedad Química y Minera de Chile S.A. has the fastest current growth.
How has Specialty Chemicals moved against S&P 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this industry is 11% behind S&P 500. Earnings across its companies fell 19% on average over the last four reported quarters.
RS — · 37/47 >200d (+6) · 15/47 lead (+3) · EPS 22/46↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the industry line is an equal-weighted index of its 47 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the industry taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is Specialty Chemicals outperforming S&P 500?
Specialty Chemicals has outperformed S&P 500 by 9.1% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 3.6%. 9 of 28 covered companies currently beat the S&P 500 on Mansfield relative strength, so leadership inside the sector is selective. Calumet, Inc. is the strongest against the sector itself at +40.5%.
Sector metric: — as of latest available · unclassified · direction unavailable.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Specialty Chemicals has outperformed S&P 500 by 9.1% over 52 weeks and 3.6% over 13 weeks. 9 of 28 covered companies beat the S&P 500 on Mansfield relative strength, while 8 of 28 beat the sector itself. LyondellBasell Industries N.V. leads with revenue of $29,673 million, based on 10 of 29 comparable companies through Mar 2026.
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1NewMarket CorporationNEU | 61.9/100Thin evidence · provisional58% evidence | BREAKING OUT | 16.9/35 Revenue — · PAT — · OPM change -1.4 pp 45% evidence | 16.1/25 ROCE 5.5% · OPM 21.4% 76% evidence | 11.4/20 P/E 17× · PEG — 15% evidence | 17.5/20 RS sector 5.4% · RS bench 8.6% · 1Y 20.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 16.1 + 11.4 + 17.5 = 61.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Sociedad Química y Minera de Chile S.A.SQM | 61.7/100Mixed-positive evidence81% evidence | ASLEEP | 28.8/35 Revenue 18.3% · PAT 48.4% · OPM change 17.4 pp 83% evidence | 15.8/25 ROCE 6.3% · OPM 41% 76% evidence | 15.1/20 P/E 28.4× · PEG 0.81 65% evidence | 2.0/20 RS sector -9.7% · RS bench -8.3% · 1Y 62.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 28.8 + 15.8 + 15.1 + 2 = 61.7 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.7% and the one-year return is 62.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3WD-40 CompanyWDFC | 61.3/100Thin evidence · provisional58% evidence | TURNING | 21.3/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 17.4/25 ROCE 10.8% · OPM 16.3% 76% evidence | 10.2/20 P/E 30.4× · PEG — 15% evidence | 12.4/20 RS sector -3.7% · RS bench -1.4% · 1Y 7.5%5 of 12 weeks ahead 100% evidence |
| Exact sum: 21.3 + 17.4 + 10.2 + 12.4 = 61.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 4Sensient Technologies CorporationSXT | 60.7/100Thin evidence · provisional58% evidence | FADING | 20.4/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 12.8/25 ROCE 3.8% · OPM 15.3% 76% evidence | 9.8/20 P/E 33.2× · PEG — 15% evidence | 17.7/20 RS sector 7.9% · RS bench 10.5% · 1Y 9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 12.8 + 9.8 + 17.7 = 60.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Quaker Chemical CorporationKWR | 57.5/100Thin evidence · provisional58% evidence | BREAKING OUT | 21.5/35 Revenue — · PAT — · OPM change 0.8 pp 45% evidence | 8.3/25 ROCE 1.7% · OPM 7% 76% evidence | 10.5/20 P/E 28.3× · PEG — 15% evidence | 17.2/20 RS sector 6% · RS bench 8.7% · 1Y 36.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 8.3 + 10.5 + 17.2 = 57.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Axalta Coating Systems Ltd.AXTA | 56.2/100Thin evidence · provisional58% evidence | BREAKING OUT | 15.3/35 Revenue — · PAT — · OPM change -2.3 pp 45% evidence | 11.7/25 ROCE 2.8% · OPM 11.6% 76% evidence | 10.8/20 P/E 21.1× · PEG — 15% evidence | 18.4/20 RS sector 6.4% · RS bench 9.2% · 1Y 32.5%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 11.7 + 10.8 + 18.4 = 56.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Ashland Inc.ASH | 54.2/100Thin evidence · provisional58% evidence | BREAKING OUT | 18.8/35 Revenue — · PAT — · OPM change -2.5 pp 45% evidence | 7.0/25 ROCE 1% · OPM 8.1% 76% evidence | 8.9/20 P/E 57.8× · PEG — 15% evidence | 19.5/20 RS sector 10.3% · RS bench 12.9% · 1Y 39%9 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 7 + 8.9 + 19.5 = 54.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8The Sherwin-Williams CompanySHW | 53.8/100Thin evidence · provisional58% evidence | TURNING | 18.7/35 Revenue — · PAT — · OPM change -0.1 pp 45% evidence | 15.5/25 ROCE 7.1% · OPM 14.2% 76% evidence | 10.0/20 P/E 31.7× · PEG — 15% evidence | 9.6/20 RS sector -6.6% · RS bench -4% · 1Y 2.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 15.5 + 10 + 9.6 = 53.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9H.B. Fuller CompanyFUL | 53.0/100Mixed-positive evidence85% evidence | BASING | 22.1/35 Revenue -0.6% · PAT 80.6% · OPM change 1.2 pp 95% evidence | 10.9/25 ROCE 2.6% · OPM 12.3% 76% evidence | 16.1/20 P/E 19× · PEG 0.5 65% evidence | 3.9/20 RS sector -14.3% · RS bench -12.2% · 1Y 4.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 10.9 + 16.1 + 3.9 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10International Flavors & Fragrances Inc.IFF | 52.4/100Mixed-positive evidence64% evidence | ASLEEP | 21.5/35 Revenue -5.6% · PAT — · OPM change 41.8 pp 62% evidence | 7.2/25 ROCE 1.2% · OPM 10% 76% evidence | 10.6/20 P/E 22.2× · PEG — 15% evidence | 13.1/20 RS sector 0% · RS bench 2.2% · 1Y 27.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 7.2 + 10.6 + 13.1 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Eastman Chemical CompanyEMN | 52.4/100Thin evidence · provisional58% evidence | ASLEEP | 18.6/35 Revenue — · PAT — · OPM change -4.6 pp 45% evidence | 13.3/25 ROCE 4.8% · OPM 8.6% 76% evidence | 11.2/20 P/E 17.4× · PEG — 15% evidence | 9.3/20 RS sector -5.5% · RS bench -3.5% · 1Y 19.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 13.3 + 11.2 + 9.3 = 52.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Avient CorporationAVNT | 52.2/100Mixed-positive evidence64% evidence | ASLEEP | 21.8/35 Revenue 1.3% · PAT 56.9% · OPM change 11.2 pp 62% evidence | 9.1/25 ROCE 1.9% · OPM 11.3% 76% evidence | 10.9/20 P/E 21.1× · PEG — 15% evidence | 10.4/20 RS sector -4.6% · RS bench -2.6% · 1Y 16.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.8 + 9.1 + 10.9 + 10.4 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Balchem CorporationBCPC | 52.2/100Thin evidence · provisional58% evidence | TURNING | 18.6/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence | 14.6/25 ROCE 3.8% · OPM 20.5% 76% evidence | 9.9/20 P/E 33.2× · PEG — 15% evidence | 9.1/20 RS sector -5.8% · RS bench -3.6% · 1Y 9.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.6 + 14.6 + 9.9 + 9.1 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14RPM International Inc.RPM | 50.2/100Thin evidence · provisional58% evidence | TURNING | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 45% evidence | 12.7/25 ROCE 4.8% · OPM 5% 76% evidence | 11.0/20 P/E 20.5× · PEG — 15% evidence | 8.2/20 RS sector -8.3% · RS bench -5.8% · 1Y -3.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 12.7 + 11 + 8.2 = 50.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15PPG Industries, Inc.PPG | 50.2/100Thin evidence · provisional58% evidence | TURNING | 16.8/35 Revenue — · PAT — · OPM change -0.2 pp 45% evidence | 12.8/25 ROCE 3.6% · OPM 13.8% 76% evidence | 11.3/20 P/E 17.4× · PEG — 15% evidence | 9.3/20 RS sector -5.7% · RS bench -3.5% · 1Y 10.1%3 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 12.8 + 11.3 + 9.3 = 50.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Element Solutions IncESI | 49.8/100Thin evidence · provisional58% evidence | ASLEEP | 17.7/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 10.6/25 ROCE 2.3% · OPM 13.3% 76% evidence | 8.8/20 P/E 64.5× · PEG — 15% evidence | 12.7/20 RS sector 6.6% · RS bench 8.2% · 1Y 62.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 17.7 + 10.6 + 8.8 + 12.7 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Linde plcLIN | 47.5/100Thin evidence · provisional58% evidence | ASLEEP | 18.8/35 Revenue — · PAT — · OPM change 0.9 pp 45% evidence | 14.3/25 ROCE 3.6% · OPM 27.8% 76% evidence | 9.7/20 P/E 33.5× · PEG — 15% evidence | 4.7/20 RS sector -10.3% · RS bench -8.3% · 1Y 2.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 14.3 + 9.7 + 4.7 = 47.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Ecolab Inc.ECL | 46.7/100Thin evidence · provisional58% evidence | TURNING | 17.0/35 Revenue — · PAT — · OPM change 0.3 pp 45% evidence | 12.9/25 ROCE 3.5% · OPM 15.3% 76% evidence | 9.5/20 P/E 37.4× · PEG — 15% evidence | 7.3/20 RS sector -9% · RS bench -6.6% · 1Y 3.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 12.9 + 9.5 + 7.3 = 46.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Cabot CorporationCBT | 46.3/100Mixed-negative evidence81% evidence | ASLEEP | 8.9/35 Revenue -8.5% · PAT -31.2% · OPM change -3 pp 83% evidence | 13.3/25 ROCE 4.5% · OPM 14.3% 76% evidence | 16.5/20 P/E 14.2× · PEG 0.18 65% evidence | 7.6/20 RS sector -5.2% · RS bench -3.1% · 1Y 5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 8.9 + 13.3 + 16.5 + 7.6 = 46.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 20Air Products and Chemicals, Inc.APD | 43.7/100Thin evidence · provisional58% evidence | BASING | 17.0/35 Revenue — · PAT — · OPM change 103.5 pp 45% evidence | 9.5/25 ROCE -5.8% · OPM 23.7% 76% evidence | 10.1/20 P/E 30.7× · PEG — 15% evidence | 7.1/20 RS sector -7% · RS bench -4.9% · 1Y 2.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 9.5 + 10.1 + 7.1 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Calumet, Inc.CLMT | 41.5/100Mixed-negative evidence64% evidence | BREAKING OUT | 9.4/35 Revenue -0.1% · PAT — · OPM change -11.7 pp 62% evidence | 3.0/25 ROCE -9.1% · OPM -16.6% 76% evidence | 10.3/20 P/E 30.3× · PEG — 15% evidence | 18.8/20 RS sector 40.5% · RS bench 42% · 1Y 189.2%9 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 3 + 10.3 + 18.8 = 41.5 · Decision use: Price leads the evidence: RS versus the benchmark is 42%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 22Perimeter Solutions, Inc.PRM | 40.4/100Thin evidence · provisional58% evidence | FADING | 10.0/35 Revenue — · PAT — · OPM change -50 pp 45% evidence | 7.5/25 ROCE -7.6% · OPM 58% 76% evidence | 9.0/20 P/E 53.3× · PEG — 15% evidence | 13.9/20 RS sector 7.8% · RS bench 10.3% · 1Y 84.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 10 + 7.5 + 9 + 13.9 = 40.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23DuPont de Nemours, Inc.DD | 38.9/100Mixed-negative evidence81% evidence | BASING | 22.2/35 Revenue 4% · PAT 40.7% · OPM change 5.2 pp 83% evidence | 7.5/25 ROCE 0.7% · OPM 11.1% 76% evidence | 4.3/20 P/E 45.4× · PEG 4.12 65% evidence | 4.9/20 RS sector -21.8% · RS bench -19.3% · 1Y -32.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 7.5 + 4.3 + 4.9 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Albemarle CorporationALB | 38.3/100Thin evidence · provisional53% evidence | ASLEEP | 20.0/35 Revenue — · PAT — · OPM change 14.5 pp 32% evidence | 9.2/25 ROCE 1.6% · OPM 16.3% 76% evidence | 9.1/20 P/E 47.9× · PEG — 15% evidence | 0.0/20 RS sector -22.9% · RS bench -21.8% · 1Y 60.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 9.2 + 9.1 + 0 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25Hawkins, Inc.HWKN | 37.8/100Thin evidence · provisional58% evidence | ASLEEP | 14.8/35 Revenue — · PAT — · OPM change -1.2 pp 45% evidence | 12.7/25 ROCE 4.4% · OPM 8.8% 76% evidence | 9.4/20 P/E 41.9× · PEG — 15% evidence | 0.9/20 RS sector -22.8% · RS bench -20.8% · 1Y -24.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 12.7 + 9.4 + 0.9 = 37.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 26LyondellBasell Industries N.V.LYB | 33.4/100Adverse evidence71% evidence | ASLEEP | 13.1/35 Revenue -9.4% · PAT -164.8% · OPM change 1.8 pp 83% evidence | 6.5/25 ROCE 0.9% · OPM 3.3% 76% evidence | 8.6/20 P/E 76.1× · PEG — 15% evidence | 5.2/20 RS sector -5.6% · RS bench -4.2% · 1Y 24.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 6.5 + 8.6 + 5.2 = 33.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27The Chemours CompanyCC | 28.8/100Adverse evidence64% evidence | ASLEEP | 12.7/35 Revenue 0.6% · PAT -3836.4% · OPM change -2 pp 62% evidence | 4.4/25 ROCE 0.5% · OPM 1.9% 76% evidence | 8.5/20 P/E 225.5× · PEG — 15% evidence | 3.2/20 RS sector -7.7% · RS bench -6.6% · 1Y 47.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 12.7 + 4.4 + 8.5 + 3.2 = 28.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Westlake CorporationWLK | 26.1/100Adverse evidence64% evidence | BASING | 9.8/35 Revenue -8.6% · PAT -473.1% · OPM change -5.4 pp 62% evidence | 4.7/25 ROCE -1% · OPM -6.5% 76% evidence | 9.6/20 P/E 33.6× · PEG — 15% evidence | 2.0/20 RS sector -17.5% · RS bench -16.2% · 1Y 2.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 9.8 + 4.7 + 9.6 + 2 = 26.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Solstice Advanced Materials, Inc.SOLS | 46.2/100Thin evidence · provisional36% evidence | ASLEEP | 12.4/35 Revenue — · PAT — · OPM change -4.5 pp 39% evidence | 15.1/25 ROCE 9.6% · OPM 16.5% 76% evidence | 8.7/20 P/E 67.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —1 of 12 weeks ahead 0% evidence |
| Exact sum: 12.4 + 15.1 + 8.7 + 10 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Market action
Calumet, Inc. has the strongest one-year price move in Specialty Chemicals at +189.2%. It also leads on Mansfield relative strength against the S&P 500 at +42%. 9 of 28 covered companies are above zero on that measure. Every line covers 314 weekly closes through 2026-08-04.
Every company, the sector's own index and S&P 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind S&P 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS S&P 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Specialty Chemicals itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Revenue Scale & Growth Durability
LyondellBasell Industries N.V. has the highest Revenue among the 29 Specialty Chemicals companies compared here, at $29,673 million. Westlake Corporation is next at $10,976 million. Sociedad Química y Minera de Chile S.A. has the highest Revenue growth at 18.3%, so level and change sit with different companies. 10 of 29 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: LyondellBasell Industries N.V. is the scale leader at $29,673 million, 170.3% ahead of Westlake Corporation. Sociedad Química y Minera de Chile S.A.'s growth is 18.3% from a $5,300 million base, with 19 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: LyondellBasell Industries N.V. is the scale benchmark; Sociedad Química y Minera de Chile S.A. is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: LyondellBasell Industries N.V.'s growth falls below Sociedad Química y Minera de Chile S.A.'s for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Linde plc LIN | $8.8B | 8.3% | Jun 2026 |
| LyondellBasell Industries N.V. LYB | $7.2B | -6.3% | Mar 2026 |
| The Sherwin-Williams Company SHW | $5.7B | 6.8% | Jun 2026 |
| Ecolab Inc. ECL | $4.1B | 10% | Jun 2026 |
| PPG Industries, Inc. PPG | $3.9B | 6.7% | Jun 2026 |
| Air Products and Chemicals, Inc. APD | $3.2B | 8.8% | Jun 2026 |
| International Flavors & Fragrances Inc. IFF | $2.7B | -3.6% | Mar 2026 |
| Westlake Corporation WLK | $2.7B | -6.8% | Mar 2026 |
| Eastman Chemical Company EMN | $2.2B | -4.9% | Jun 2026 |
| Sociedad Química y Minera de Chile S.A. SQM | $1.8B | 70% | Mar 2026 |
| DuPont de Nemours, Inc. DD | $1.7B | 4.3% | Mar 2026 |
| RPM International Inc. RPM | $1.6B | 8.9% | Jun 2026 |
| Albemarle Corporation ALB | $1.4B | 33% | Mar 2026 |
| The Chemours Company CC | $1.4B | 1.0% | Mar 2026 |
| Axalta Coating Systems Ltd. AXTA | $1.3B | -0.6% | Jun 2026 |
| Calumet, Inc. CLMT | $1.0B | 3.6% | Mar 2026 |
| Solstice Advanced Materials, Inc. SOLS | $991M | 10% | Jun 2026 |
| H.B. Fuller Company FUL | $950M | 5.8% | Jun 2026 |
| Cabot Corporation CBT | $904M | -3.4% | Mar 2026 |
| Avient Corporation AVNT | $847M | 2.4% | Mar 2026 |
| Element Solutions Inc ESI | $840M | 41% | Jun 2026 |
| NewMarket Corporation NEU | $670M | -4.4% | Jun 2026 |
| Ashland Inc. ASH | $482M | 0.6% | Jun 2026 |
| Quaker Chemical Corporation KWR | $480M | 8.4% | Jun 2026 |
| Sensient Technologies Corporation SXT | $436M | 11% | Jun 2026 |
| Balchem Corporation BCPC | $271M | 8.0% | Jun 2026 |
| Hawkins, Inc. HWKN | $266M | 8.6% | Jun 2026 |
| WD-40 Company WDFC | $162M | 11% | Jun 2026 |
| Perimeter Solutions, Inc. PRM | $125M | 74% | Jun 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Revenue growth · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Operating Economics & Margin Trend
Perimeter Solutions, Inc. has the highest OPM among the 29 Specialty Chemicals companies compared here, at 58%. Sociedad Química y Minera de Chile S.A. is next at 41%. Air Products and Chemicals, Inc. has the highest Margin change at +103.5 percentage points, so level and change sit with different companies.
What the numbers say: Perimeter Solutions, Inc. leads opm at 58%; Air Products and Chemicals, Inc. leads margin change at +103.5 percentage points.
Investor read: Perimeter Solutions, Inc. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Perimeter Solutions, Inc. PRM | 58% | −50.0 pp | Jun 2026 |
| Sociedad Química y Minera de Chile S.A. SQM | 41% | +17.4 pp | Mar 2026 |
| Linde plc LIN | 28% | +0.9 pp | Jun 2026 |
| Air Products and Chemicals, Inc. APD | 24% | +103.5 pp | Jun 2026 |
| NewMarket Corporation NEU | 21% | −1.4 pp | Jun 2026 |
| Balchem Corporation BCPC | 21% | +0.1 pp | Jun 2026 |
| Solstice Advanced Materials, Inc. SOLS | 17% | −4.5 pp | Jun 2026 |
| Albemarle Corporation ALB | 16% | +14.5 pp | Mar 2026 |
| WD-40 Company WDFC | 16% | +0.4 pp | Jun 2026 |
| Ecolab Inc. ECL | 15% | +0.3 pp | Jun 2026 |
| Sensient Technologies Corporation SXT | 15% | +1.7 pp | Jun 2026 |
| Cabot Corporation CBT | 14% | −3.0 pp | Mar 2026 |
| The Sherwin-Williams Company SHW | 14% | −0.1 pp | Jun 2026 |
| PPG Industries, Inc. PPG | 14% | −0.2 pp | Jun 2026 |
| Element Solutions Inc ESI | 13% | +0.3 pp | Jun 2026 |
| H.B. Fuller Company FUL | 12% | +1.2 pp | Jun 2026 |
| Axalta Coating Systems Ltd. AXTA | 12% | −2.3 pp | Jun 2026 |
| Avient Corporation AVNT | 11% | +11.2 pp | Mar 2026 |
| DuPont de Nemours, Inc. DD | 11% | +5.2 pp | Mar 2026 |
| International Flavors & Fragrances Inc. IFF | 10% | +41.8 pp | Mar 2026 |
| Hawkins, Inc. HWKN | 8.8% | −1.2 pp | Jun 2026 |
| Eastman Chemical Company EMN | 8.6% | −4.6 pp | Jun 2026 |
| Ashland Inc. ASH | 8.1% | −2.5 pp | Jun 2026 |
| Quaker Chemical Corporation KWR | 7.0% | +0.8 pp | Jun 2026 |
| RPM International Inc. RPM | 5.0% | +0.8 pp | Jun 2026 |
| LyondellBasell Industries N.V. LYB | 3.3% | +1.8 pp | Mar 2026 |
| The Chemours Company CC | 1.9% | −2.0 pp | Mar 2026 |
| Westlake Corporation WLK | -6.5% | −5.4 pp | Mar 2026 |
| Calumet, Inc. CLMT | -17% | −11.7 pp | Mar 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Margin change · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Profit Scale & Acceleration
Sociedad Química y Minera de Chile S.A. has the highest Net profit among the 29 Specialty Chemicals companies compared here, at $905 million. International Flavors & Fragrances Inc. is next at $854 million. H.B. Fuller Company has the highest Profit growth at 80.6%, so level and change sit with different companies.
What the numbers say: Sociedad Química y Minera de Chile S.A. leads with $905 million of TTM profit, 6% above International Flavors & Fragrances Inc.. H.B. Fuller Company shows 80.6% growth from a $186 million profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: Sociedad Química y Minera de Chile S.A. sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Profit growth · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Return On Capital Employed
WD-40 Company has the highest ROCE among the 29 Specialty Chemicals companies compared here, at 10.8%. Solstice Advanced Materials, Inc. is next at 9.6%. Ashland Inc. has the highest ROCE change at +15.9 percentage points, so level and change sit with different companies. 29 of 29 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: WD-40 Company leads ROCE at 10.8%, 1.2 percentage points above Solstice Advanced Materials, Inc.. Ashland Inc. has the strongest latest improvement at +15.9 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: WD-40 Company sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| WD-40 Company WDFC | 11% | +3.0 pp | Jun 2026 |
| Solstice Advanced Materials, Inc. SOLS | 9.6% | −6.3 pp | Jun 2026 |
| The Sherwin-Williams Company SHW | 7.1% | +0.5 pp | Jun 2026 |
| Sociedad Química y Minera de Chile S.A. SQM | 6.3% | +3.5 pp | Mar 2026 |
| NewMarket Corporation NEU | 5.5% | +0.3 pp | Jun 2026 |
| RPM International Inc. RPM | 4.8% | −0.1 pp | Jun 2026 |
| Eastman Chemical Company EMN | 4.8% | +3.0 pp | Jun 2026 |
| Cabot Corporation CBT | 4.5% | −1.0 pp | Mar 2026 |
| Hawkins, Inc. HWKN | 4.4% | −1.2 pp | Jun 2026 |
| Balchem Corporation BCPC | 3.8% | +0.4 pp | Jun 2026 |
| Sensient Technologies Corporation SXT | 3.8% | +0.7 pp | Jun 2026 |
| Linde plc LIN | 3.6% | +0.2 pp | Jun 2026 |
| PPG Industries, Inc. PPG | 3.6% | −0.2 pp | Jun 2026 |
| Ecolab Inc. ECL | 3.5% | −0.4 pp | Jun 2026 |
| Axalta Coating Systems Ltd. AXTA | 2.8% | −0.3 pp | Jun 2026 |
| H.B. Fuller Company FUL | 2.6% | +0.3 pp | Jun 2026 |
| Element Solutions Inc ESI | 2.3% | +0.3 pp | Jun 2026 |
| Avient Corporation AVNT | 1.9% | +1.9 pp | Mar 2026 |
| Quaker Chemical Corporation KWR | 1.7% | +3.9 pp | Jun 2026 |
| Albemarle Corporation ALB | 1.6% | +1.5 pp | Mar 2026 |
| International Flavors & Fragrances Inc. IFF | 1.2% | +4.8 pp | Mar 2026 |
| Ashland Inc. ASH | 1.0% | +15.9 pp | Jun 2026 |
| LyondellBasell Industries N.V. LYB | 0.9% | +0.5 pp | Mar 2026 |
| DuPont de Nemours, Inc. DD | 0.7% | +0.4 pp | Mar 2026 |
| The Chemours Company CC | 0.5% | −0.4 pp | Mar 2026 |
| Westlake Corporation WLK | -1.0% | −0.8 pp | Mar 2026 |
| Air Products and Chemicals, Inc. APD | -5.8% | −8.1 pp | Jun 2026 |
| Perimeter Solutions, Inc. PRM | -7.6% | −6.5 pp | Jun 2026 |
| Calumet, Inc. CLMT | -9.1% | −6.2 pp | Mar 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
ROCE change · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
Valuation Against Growth & Quality
Cabot Corporation has the lowest PEG among the 29 Specialty Chemicals companies compared here, at 0.18×. H.B. Fuller Company is next at 0.5×. The same company also holds the lowest P/E, at 14.2×. 4 of 29 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: Cabot Corporation has the lowest comparable PEG at 0.18×, 64% below H.B. Fuller Company. Only 4 of 29 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
Full 20-quarter history · every available company
PEG · reported quarter history
Showing the 12 largest of 21 companies with a series here. The remaining 9 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
DuPont de Nemours, Inc. · DD
Eastman Chemical Company · EMN
Ecolab Inc. · ECL
Element Solutions Inc · ESI
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
P/E · reported quarter history
Showing the 12 largest of 29 companies with a series here. The remaining 17 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Air Products and Chemicals, Inc. · APD
Albemarle Corporation · ALB
DuPont de Nemours, Inc. · DD
Ecolab Inc. · ECL
International Flavors & Fragrances Inc. · IFF
Linde plc · LIN
LyondellBasell Industries N.V. · LYB
PPG Industries, Inc. · PPG
RPM International Inc. · RPM
Sociedad Química y Minera de Chile S.A. · SQM
The Sherwin-Williams Company · SHW
Westlake Corporation · WLK
What can make this comparison misleading?
This Specialty Chemicals comparison names 4 specific ways its own evidence can mislead, all listed below. All 29 companies here report on comparable dates, so no rank carries a stale marker. A high growth rate can still be a low-base artefact.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
How was this comparison built?
This comparison is built from the reported filings of 29 Specialty Chemicals companies, normalized to a common $ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-08-04. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
Specialty Chemicals company comparison FAQs
These 22 answers restate the Specialty Chemicals comparison above in question form. Every one is computed from the same 29 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-08-04. Nothing here is estimated, and none of it is a recommendation.
Is the Specialty Chemicals sector outperforming S&P 500?
Specialty Chemicals has outperformed S&P 500 by 9.1% over 52 weeks and 3.6% over 13 weeks. 9 of 28 covered companies beat the S&P 500 on Mansfield relative strength, while 8 of 28 beat the sector itself.
Which Specialty Chemicals company is largest by revenue?
LyondellBasell Industries N.V. leads with revenue of $29,673 million, based on 10 of 29 comparable companies through Mar 2026.
Which Specialty Chemicals company is growing fastest?
Sociedad Química y Minera de Chile S.A. has the fastest current revenue growth at 18.3%, across 10 of 29 comparable companies.
Which Specialty Chemicals company has the strongest 4-Factor Sector Score?
NewMarket Corporation ranks first at 61.9/100 with 57.8% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Specialty Chemicals company has the lowest comparable PEG?
Cabot Corporation has the lowest comparable PEG at 0.18, among 4 of 29 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Specialty Chemicals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
Which Specialty Chemicals company is the biggest?
LyondellBasell Industries N.V. is the largest, with trailing-twelve-month revenue of $29,673 million, ahead of Westlake Corporation at $10,976 million. That covers 10 of 29 companies with comparable reporting through Mar 2026.
Which Specialty Chemicals company has the best profit margins?
Perimeter Solutions, Inc. has the highest operating margin at 58%, from 29 of 29 comparable companies. Air Products and Chemicals, Inc. shows the biggest recent improvement, at +103.5 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Specialty Chemicals company makes the most profit?
Sociedad Química y Minera de Chile S.A. earns the most, at $905 million of trailing-twelve-month net profit, from 10 of 29 comparable companies. H.B. Fuller Company has the fastest profit growth at 80.6%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Specialty Chemicals company earns the highest return on capital?
WD-40 Company leads on return on capital employed at 10.8%, across 29 of 29 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Specialty Chemicals stock is the cheapest?
On PEG — where a LOWER number is cheaper — Cabot Corporation screens cheapest at 0.18×. Only 4 of 29 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Specialty Chemicals sector beating the market?
Specialty Chemicals has outperformed S&P 500 by 9.1% over the last 52 weeks and 3.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 9 of 28 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Specialty Chemicals stock has the strongest price momentum?
Calumet, Inc. has the strongest relative strength against S&P 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Specialty Chemicals company scores highest for research priority?
NewMarket Corporation scores 61.9 out of 100 with 57.8% evidence confidence, from 16.9 points on growth and earnings, 16.1 on capital efficiency, 11.4 on valuation and 17.5 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Specialty Chemicals companies does this comparison cover, and over what period?
It compares 29 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Specialty Chemicals sector?
The 29 Specialty Chemicals companies on this page carry $690,867 million of combined market value. Linde plc is the largest at $223,409 million, about 32% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-04.
What is the Specialty Chemicals sector's P/E ratio?
The median price-to-earnings ratio across the 29 Specialty Chemicals companies on this page is 31.7×, measured on the 29 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-04.
How is the Specialty Chemicals sector performing?
9 of the 28 covered Specialty Chemicals companies are beating S&P 500 on Mansfield relative strength. The sector itself is 9.1% ahead of S&P 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-04.
How many Specialty Chemicals stocks are listed in the US?
This comparison covers 29 listed Specialty Chemicals companies in the US, each above the size floor the site applies. The full ranked list is on this page, with reported fundamentals through Jun 2026. Membership is the full industry list — nothing is dropped for having thin data.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.